InvestorsHub Logo
Followers 39
Posts 1525
Boards Moderated 0
Alias Born 07/10/2014

Re: iReapZzYy post# 1998110

Monday, 09/28/2015 11:38:16 PM

Monday, September 28, 2015 11:38:16 PM

Post# of 2804248
Aeterna Zentaris Announces Data and Safety Monitoring Board Scheduled to Complete Second Interim Analysis of the ZoptEC Phase 3 Trial in Endometrial Cancer in Early October.

http://finance.yahoo.com/news/aeterna-zentaris-announces-data-safety-113000737.html

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.